Skip to main content

Classification, Causes, and Epidemiology

  • Chapter
  • First Online:
Handbook of Depression

Abstract

The depressive disorders comprise a heterogeneous group of illnesses that are characterized by differing degrees of affective lability and associated cognitive, neurovegetative, and psychomotor alterations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet. 1997;349:1498-1504.

    Google Scholar 

  2. Lopez AD, Mathers CD. Measuring the global burden of disease and epidemiological transitions: 2002–2030. Ann Tropical Med Parasitol. 2006;100:481-499.

    Google Scholar 

  3. Remick RA, Sadovnick AD, Lam RW, et al. Major depression, minor depression, and double depression: are they distinct clinical entities? Am J Med Genet. 1996;67:347-353.

    Google Scholar 

  4. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Washington DC: APA;2013.

    Google Scholar 

  5. World Health Organization. International Classification of Mental and Behavioral Disorders, 10th revision (ICD-10). Geneva: WHO, 1992.

    Google Scholar 

  6. Bostwick JM, Pankratz VS. Affective disorder and suicide risk: a reexamination. Am J Psychiatry. 2000;157:1924-1932.

    Google Scholar 

  7. Kandel ER. A new intellectual framework for psychiatry. Am J Psychiatry. 1998;55:457-469.

    Google Scholar 

  8. Caspi A, Sudgen K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386-389.

    Google Scholar 

  9. Richelson E. The clinical relevance of antidepressant interaction with neurotransmitter transporters and receptors. Psychopharmacol Bull. 2002;36:133-150.

    Google Scholar 

  10. Brown WG, Craig TKJ, Harris TO. Parental maltreatment and proximal risk factors using the Childhood Experience of Care and Abuse (CECA) instrument: a life course study of adult chronic depression – 5. J Affect Disord. 2008; 110:222-233.

    Google Scholar 

  11. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105.

    Google Scholar 

  12. Waraich P, Goldner EM, Somers JM, et al. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 2004; 49:124-138.

    Google Scholar 

  13. Rush AJ. STAR*D: What have we learned? Am J Psychiatry. 2007;164:201-204.

    Google Scholar 

  14. Mueller TI, Leon AC. Recovery, chronicity, and levels of psychopathology in major depressive disorder. Psychiatr Clin North Am. 1996;19:85-102.

    Google Scholar 

  15. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am. 1996;19:179-200.

    Google Scholar 

  16. Judd LL, Akiskal HS, Maser JD, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry. 1998;55:694-700.

    Google Scholar 

  17. AHCPR Depression Guideline Panel. Clinical Practice Guideline. Number 5. Depression in Primary Care, Vol 1. Detection and Diagnosis. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research;1993.

    Google Scholar 

  18. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994; 51:8-19

    Google Scholar 

  19. Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342:1462-1470.

    Google Scholar 

  20. Nemeroff CB, Heim CM, Thase ME, et al. Differential responses to psychotherapy versus pharmacotherapy in the treatment of patients with chronic forms of depression. Proc Natl Acad Sci USA. 2003;100:14293-14296.

    Google Scholar 

  21. Schatzberg AF, Rush AJ, Arnow BA, et al. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry. 2005;62:513-520.

    Google Scholar 

  22. O’Hara MW, Swain AM. Rates and risk of postpartum depression: a meta analysis. Int Rev Psychiatry. 1996; 8:37-54.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edward S. Friedman .

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Healthcare

About this chapter

Cite this chapter

Friedman, E.S., Anderson, I.M. (2014). Classification, Causes, and Epidemiology. In: Handbook of Depression. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-907673-79-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-907673-79-5_1

  • Published:

  • Publisher Name: Springer Healthcare, Tarporley

  • Print ISBN: 978-1-907673-78-8

  • Online ISBN: 978-1-907673-79-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics